These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24490672)

  • 1. Status of drug development for the prevention and treatment of osteoporosis.
    Schwarz P; Jørgensen NR; Abrahamsen B
    Expert Opin Drug Discov; 2014 Mar; 9(3):245-53. PubMed ID: 24490672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Innovations in the treatment of osteoporosis].
    Tsourdi E; Hofbauer LC
    Dtsch Med Wochenschr; 2011 Dec; 136(48):2458-60. PubMed ID: 22109575
    [No Abstract]   [Full Text] [Related]  

  • 3. Short-term and long-term effects of osteoporosis therapies.
    Reid IR
    Nat Rev Endocrinol; 2015 Jul; 11(7):418-28. PubMed ID: 25963272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoporosis: now and the future.
    Rachner TD; Khosla S; Hofbauer LC
    Lancet; 2011 Apr; 377(9773):1276-87. PubMed ID: 21450337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New therapeutics for osteoporosis.
    Ng KW; Martin TJ
    Curr Opin Pharmacol; 2014 Jun; 16():58-63. PubMed ID: 24699340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two pioneering osteoporosis drugs finally approach approval.
    Garber K
    Nat Rev Drug Discov; 2016 Jun; 15(7):445-6. PubMed ID: 27357010
    [No Abstract]   [Full Text] [Related]  

  • 7. Emerging drugs for osteoporosis.
    Feurer E; Chapurlat R
    Expert Opin Emerg Drugs; 2014 Sep; 19(3):385-95. PubMed ID: 24995794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cathepsin K inhibitors and antisclerostin antibodies. The next treatments for osteoporosis?
    Chapurlat R
    Joint Bone Spine; 2016 May; 83(3):254-6. PubMed ID: 26919802
    [No Abstract]   [Full Text] [Related]  

  • 9. Appropriate models for novel osteoporosis drug discovery and future perspectives.
    Gennari L; Rotatori S; Bianciardi S; Gonnelli S; Nuti R; Merlotti D
    Expert Opin Drug Discov; 2015; 10(11):1201-16. PubMed ID: 26292627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future directions for new medical entities in osteoporosis.
    Ferrari S
    Best Pract Res Clin Endocrinol Metab; 2014 Dec; 28(6):859-70. PubMed ID: 25432357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Odanacatib for the treatment of osteoporosis.
    Boggild MK; Gajic-Veljanoski O; McDonald-Blumer H; Ridout R; Tile L; Josse R; Cheung AM
    Expert Opin Pharmacother; 2015; 16(11):1717-26. PubMed ID: 26149759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of osteoporosis treatment - a research update.
    Lippuner K
    Swiss Med Wkly; 2012; 142():w13624. PubMed ID: 22815185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Osteoanabolics and the forthcoming drugs for the treatment of osteoporosis].
    Grazio S
    Reumatizam; 2014; 61(2):95-9. PubMed ID: 25427402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological agents in management of osteoporosis.
    Tella SH; Gallagher JC
    Eur J Clin Pharmacol; 2014 Nov; 70(11):1291-301. PubMed ID: 25204309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Romosozumab for the treatment of osteoporosis.
    Bandeira L; Lewiecki EM; Bilezikian JP
    Expert Opin Biol Ther; 2017 Feb; 17(2):255-263. PubMed ID: 28064540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of osteoporosis in rheumatoid arthritis patients.
    Hoes JN; Bultink IE; Lems WF
    Expert Opin Pharmacother; 2015 Mar; 16(4):559-71. PubMed ID: 25626121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New therapeutic targets for osteoporosis: beyond denosumab.
    Lim V; Clarke BL
    Maturitas; 2012 Nov; 73(3):269-72. PubMed ID: 22925430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of postmenopausal osteoporosis and the prevention of fractures.
    Gambacciani M; Levancini M
    Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New targets for intervention in the treatment of postmenopausal osteoporosis.
    Lewiecki EM
    Nat Rev Rheumatol; 2011 Sep; 7(11):631-8. PubMed ID: 21931340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Established and forthcoming drugs for the treatment of osteoporosis.
    Lems WF; Geusens P
    Curr Opin Rheumatol; 2014 May; 26(3):245-51. PubMed ID: 24625372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.